Effects of Dietary Oleacein Treatment on Endothelial Dysfunction and Lupus Nephritis in Balb/C Pristane-Induced Mice.
Rocío Muñoz-GarcíaMarina Sánchez-HidalgoManuel AlcarranzaMaría Victoria Vázquez-RománMaría Alvarez de SotomayorMaría Luisa González-RodríguezMaría C de AndrésCatalina Alarcón-de-la-LastraPublished in: Antioxidants (Basel, Switzerland) (2023)
Systemic lupus erythematosus (SLE) is a chronic immune-inflammatory disease characterized by multiorgan affectation and lowered self-tolerance. Additionally, epigenetic changes have been described as playing a pivotal role in SLE. This work aims to assess the effects of oleacein (OLA), one of the main extra virgin olive oil secoiridoids, when used to supplement the diet of a murine pristane-induced SLE model. In the study, 12-week-old female BALB/c mice were injected with pristane and fed with an OLA-enriched diet (0.01 % ( w / w )) for 24 weeks. The presence of immune complexes was evaluated by immunohistochemistry and immunofluorescence. Endothelial dysfunction was studied in thoracic aortas. Signaling pathways and oxidative-inflammatory-related mediators were evaluated by Western blotting. Moreover, we studied epigenetic changes such as DNA methyltransferase (DNMT-1) and micro(mi)RNAs expression in renal tissue. Nutritional treatment with OLA reduced the deposition of immune complexes, ameliorating kidney damage. These protective effects could be related to the modulation of mitogen-activated protein kinases, the Janus kinase/signal transducer and transcription activator of transcription, nuclear factor kappa, nuclear-factor-erythroid-2-related factor 2, inflammasome signaling pathways, and the regulation of miRNAs (miRNA-126, miRNA-146a, miRNA-24-3p, and miRNA-123) and DNMT-1 expression. Moreover, the OLA-enriched diet normalized endothelial nitric oxide synthase and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-1 overexpression. These preliminary results suggest that an OLA-supplemented diet could constitute a new alternative nutraceutical therapy in the management of SLE, supporting this compound as a novel epigenetic modulator of the immunoinflammatory response.
Keyphrases
- nuclear factor
- systemic lupus erythematosus
- toll like receptor
- dna methylation
- disease activity
- physical activity
- weight loss
- nitric oxide synthase
- oxidative stress
- signaling pathway
- poor prognosis
- gene expression
- diabetic rats
- high glucose
- drug induced
- nitric oxide
- transcription factor
- rheumatoid arthritis
- spinal cord
- cell proliferation
- single molecule
- high fat diet induced
- stem cells
- binding protein
- spinal cord injury
- randomized controlled trial
- cell therapy
- metabolic syndrome
- fatty acid
- type diabetes
- adipose tissue
- protein kinase
- smoking cessation
- cell free
- preterm birth